Household transmission of SARS-CoV-2 during the Omicron wave in Shanghai, China: A case-ascertained study
- PMID: 36843225
- PMCID: PMC9946695
- DOI: 10.1111/irv.13097
Household transmission of SARS-CoV-2 during the Omicron wave in Shanghai, China: A case-ascertained study
Abstract
Objectives: We used a case-ascertained study to determine the features of household transmission of SARS-CoV-2 Omicron variant in Shanghai, China.
Methods: In April 2022, we carried out a household transmission study from 309 households of 335 SARS-CoV-2 pediatric cases referred to a designated tertiary Children's Hospital. The detailed information can be collected from the 297 households for estimating the transmission parameters. The 236 households were qualified for estimating the secondary infection attack rates (SARI ) and secondary clinical attack rates (SARC ) among adult household contacts, characterizing the transmission heterogeneities in infectivity and susceptibility, and assessing the vaccine effectiveness.
Results: We estimated the mean incubation period and serial interval of Omicron variant to be 4.6 ± 2.1 and 3.9 ± 3.7 days, respectively, with 57.2% of the transmission events occurring at the presymptomatic phase. The overall SARI and SARC among adult household contacts were 77.11% (95% confidence interval [CI]: 73.58%-80.63%) and 67.03% (63.09%-70.98%). We found higher household susceptibility in females. Infectivity was not significantly different between children and adults and symptomatic and asymptomatic cases. Two-dose and booster-dose of inactivated COVID-19 vaccination were 14.8% (5.8%-22.9%) and 18.9% (9.0%-27.7%) effective against Omicron infection and 21.5% (10.4%-31.2%) and 24.3% (12.3%-34.7%) effective against the symptomatic disease.
Conclusions: We found high household transmission during the Omicron wave in Shanghai due to presymptomatic and asymptomatic transmission despite implementation of strict interventions, indicating the importance of early detection and timely isolation of SARS-CoV-2 infections. Marginal effectiveness of inactivated vaccines against Omicron infection poses a great challenge for outbreak containment.
Keywords: Omicron variant; SARS-CoV-2; household transmission; vaccine effectiveness.
© 2023 The Authors. Influenza and Other Respiratory Viruses published by John Wiley & Sons Ltd.
Conflict of interest statement
All the authors declared no conflicts of interest related to this work.
Figures


Similar articles
-
Transmission characteristics and inactivated vaccine effectiveness against transmission of the SARS-CoV-2 Omicron BA.2 variant in Shenzhen, China.Front Immunol. 2024 Jan 8;14:1290279. doi: 10.3389/fimmu.2023.1290279. eCollection 2023. Front Immunol. 2024. PMID: 38259438 Free PMC article.
-
Transmission Characteristics and Inactivated Vaccine Effectiveness Against Transmission of SARS-CoV-2 Omicron BA.5 Variants in Urumqi, China.JAMA Netw Open. 2023 Mar 1;6(3):e235755. doi: 10.1001/jamanetworkopen.2023.5755. JAMA Netw Open. 2023. PMID: 36995713 Free PMC article.
-
Effectiveness of the booster dose of inactivated COVID-19 vaccine against Omicron BA.5 infection: a matched cohort study of adult close contacts.Respir Res. 2023 Oct 12;24(1):246. doi: 10.1186/s12931-023-02542-y. Respir Res. 2023. PMID: 37828565 Free PMC article.
-
Household Secondary Attack Rates of SARS-CoV-2 by Variant and Vaccination Status: An Updated Systematic Review and Meta-analysis.JAMA Netw Open. 2022 Apr 1;5(4):e229317. doi: 10.1001/jamanetworkopen.2022.9317. JAMA Netw Open. 2022. PMID: 35482308 Free PMC article.
-
Household Transmission of SARS-CoV-2: A Systematic Review and Meta-analysis.JAMA Netw Open. 2020 Dec 1;3(12):e2031756. doi: 10.1001/jamanetworkopen.2020.31756. JAMA Netw Open. 2020. PMID: 33315116 Free PMC article.
Cited by
-
Assessing the feasibility of sustaining SARS-CoV-2 local containment in China in the era of highly transmissible variants.BMC Med. 2022 Nov 15;20(1):442. doi: 10.1186/s12916-022-02640-6. BMC Med. 2022. PMID: 36380354 Free PMC article.
-
Risk Factors for COVID-19 Cluster Infection in Hospitalized Patients.Cureus. 2024 Apr 10;16(4):e57957. doi: 10.7759/cureus.57957. eCollection 2024 Apr. Cureus. 2024. PMID: 38738096 Free PMC article.
-
Impact of disease severity, age, sex, comorbidity, and vaccination on secondary attack rates of SARS-CoV-2: a global systematic review and meta-analysis.BMC Infect Dis. 2025 Feb 13;25(1):215. doi: 10.1186/s12879-025-10610-5. BMC Infect Dis. 2025. PMID: 39948450 Free PMC article.
-
New variants of COVID-19 (XBB.1.5 and XBB.1.16, the "Arcturus"): A review of highly questioned concerns, a brief comparison between different peaks in the COVID-19 pandemic, with a focused systematic review on expert recommendations for prevention, vaccination, and treatment measures in the general population and at-risk groups.Immun Inflamm Dis. 2024 Jun;12(6):e1323. doi: 10.1002/iid3.1323. Immun Inflamm Dis. 2024. PMID: 38938013 Free PMC article.
-
Overestimation of Severe Acute Respiratory Syndrome Coronavirus 2 Household Transmission in Settings of High Community Transmission: Insights From an Informal Settlement Community in Salvador, Brazil.Open Forum Infect Dis. 2024 Feb 5;11(3):ofae065. doi: 10.1093/ofid/ofae065. eCollection 2024 Mar. Open Forum Infect Dis. 2024. PMID: 38516384 Free PMC article.
References
-
- World Health Organization . WHO Health Emergency Dashboard. Available at: https://covid19.who.int/. Accessed 6 July 2022.
-
- World Health Organization . Weekly epidemiological update on COVID‐19‐1 March 2022. Available from: https://www.who.int/publications/m/item/weekly-epidemiological-update-on.... Accessed 31 March 2022.
-
- World Health Organization . Enhancing response to Omicron SARS‐CoV‐2 variant: Technical brief and priority actions for Member States. Available at: https://www.who.int/publications/m/item/enhancing-readiness-for-omicron-.... Accessed 22 April 2022.
-
- National Health Commission of The People's Republic of China . Technical guideline for COVID‐19 vaccination (the first version). 29 March 2021. Available from: http://www.nhc.gov.cn/jkj/s3582/202103/c2febfd04fc5498f916b1be080905771..... Accessed 22 April 2022.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous